APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydrocodeine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dihydrocodeine Industry Research Report 2026

19 December 2025130 pages

Choose your research edition.

Industry ResearchDihydrocodeine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydrocodeine Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Dihydrocodeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydrocodeine Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydrocodeine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Dihydrocodeine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dihydrocodeine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dihydrocodeine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dihydrocodeine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dihydrocodeine include AHPL, Aspen Pharmacare, Auden Mckenzie Pharma, Daiichi Sankyo, Duopharma Biotech Berhad, Fuso Pharmaceutical, G.L. Pharma, Martindale-Hubbell and Mundipharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dihydrocodeine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dihydrocodeine Market by Company

AHPL

Aspen Pharmacare

Auden Mckenzie Pharma

Daiichi Sankyo

Duopharma Biotech Berhad

Fuso Pharmaceutical

G.L. Pharma

Martindale-Hubbell

Mundipharma

Napp Pharmaceuticals

Nichi-Iko Pharmaceutical

Takata Pharmaceutical

Teofarma

Toyo Seikan Group

Wockhardt

WraSer

GlaxoSmithKline

Teva

Dihydrocodeine Segment by Type

Oral

Injection

Dihydrocodeine Segment by Application

Cough Suppressant

Analgesic

Dihydrocodeine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydrocodeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydrocodeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydrocodeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dihydrocodeine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dihydrocodeine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dihydrocodeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dihydrocodeine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dihydrocodeine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Dihydrocodeine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dihydrocodeine Revenue of Manufacturers (2021-2026) Table 9. Global Dihydrocodeine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dihydrocodeine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Dihydrocodeine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dihydrocodeine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dihydrocodeine, Product Type & Application Table 14. Global Dihydrocodeine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dihydrocodeine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AHPL Company Information Table 19. AHPL Business Overview Table 20. AHPL Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. AHPL Dihydrocodeine Product Portfolio Table 22. AHPL Recent Developments Table 23. Aspen Pharmacare Company Information Table 24. Aspen Pharmacare Business Overview Table 25. Aspen Pharmacare Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Aspen Pharmacare Dihydrocodeine Product Portfolio Table 27. Aspen Pharmacare Recent Developments Table 28. Auden Mckenzie Pharma Company Information Table 29. Auden Mckenzie Pharma Business Overview Table 30. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Auden Mckenzie Pharma Dihydrocodeine Product Portfolio Table 32. Auden Mckenzie Pharma Recent Developments Table 33. Daiichi Sankyo Company Information Table 34. Daiichi Sankyo Business Overview Table 35. Daiichi Sankyo Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Daiichi Sankyo Dihydrocodeine Product Portfolio Table 37. Daiichi Sankyo Recent Developments Table 38. Duopharma Biotech Berhad Company Information Table 39. Duopharma Biotech Berhad Business Overview Table 40. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Duopharma Biotech Berhad Dihydrocodeine Product Portfolio Table 42. Duopharma Biotech Berhad Recent Developments Table 43. Fuso Pharmaceutical Company Information Table 44. Fuso Pharmaceutical Business Overview Table 45. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Fuso Pharmaceutical Dihydrocodeine Product Portfolio Table 47. Fuso Pharmaceutical Recent Developments Table 48. G.L. Pharma Company Information Table 49. G.L. Pharma Business Overview Table 50. G.L. Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. G.L. Pharma Dihydrocodeine Product Portfolio Table 52. G.L. Pharma Recent Developments Table 53. Martindale-Hubbell Company Information Table 54. Martindale-Hubbell Business Overview Table 55. Martindale-Hubbell Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Martindale-Hubbell Dihydrocodeine Product Portfolio Table 57. Martindale-Hubbell Recent Developments Table 58. Mundipharma Company Information Table 59. Mundipharma Business Overview Table 60. Mundipharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Mundipharma Dihydrocodeine Product Portfolio Table 62. Mundipharma Recent Developments Table 63. Napp Pharmaceuticals Company Information Table 64. Napp Pharmaceuticals Business Overview Table 65. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Napp Pharmaceuticals Dihydrocodeine Product Portfolio Table 67. Napp Pharmaceuticals Recent Developments Table 68. Nichi-Iko Pharmaceutical Company Information Table 69. Nichi-Iko Pharmaceutical Business Overview Table 70. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Nichi-Iko Pharmaceutical Dihydrocodeine Product Portfolio Table 72. Nichi-Iko Pharmaceutical Recent Developments Table 73. Takata Pharmaceutical Company Information Table 74. Takata Pharmaceutical Business Overview Table 75. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Takata Pharmaceutical Dihydrocodeine Product Portfolio Table 77. Takata Pharmaceutical Recent Developments Table 78. Teofarma Company Information Table 79. Teofarma Business Overview Table 80. Teofarma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teofarma Dihydrocodeine Product Portfolio Table 82. Teofarma Recent Developments Table 83. Toyo Seikan Group Company Information Table 84. Toyo Seikan Group Business Overview Table 85. Toyo Seikan Group Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Toyo Seikan Group Dihydrocodeine Product Portfolio Table 87. Toyo Seikan Group Recent Developments Table 88. Wockhardt Company Information Table 89. Wockhardt Business Overview Table 90. Wockhardt Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Wockhardt Dihydrocodeine Product Portfolio Table 92. Wockhardt Recent Developments Table 93. WraSer Company Information Table 94. WraSer Business Overview Table 95. WraSer Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. WraSer Dihydrocodeine Product Portfolio Table 97. WraSer Recent Developments Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Dihydrocodeine Product Portfolio Table 102. GlaxoSmithKline Recent Developments Table 103. Teva Company Information Table 104. Teva Business Overview Table 105. Teva Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Teva Dihydrocodeine Product Portfolio Table 107. Teva Recent Developments Table 108. Global Dihydrocodeine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Dihydrocodeine Sales by Region (2021-2026) & (K Units) Table 110. Global Dihydrocodeine Sales Market Share by Region (2021-2026) Table 111. Global Dihydrocodeine Sales by Region (2027-2032) & (K Units) Table 112. Global Dihydrocodeine Sales Market Share by Region (2027-2032) Table 113. Global Dihydrocodeine Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Dihydrocodeine Revenue Market Share by Region (2021-2026) Table 115. Global Dihydrocodeine Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Dihydrocodeine Revenue Market Share by Region (2027-2032) Table 117. North America Dihydrocodeine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 119. North America Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 120. North America Dihydrocodeine Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Dihydrocodeine Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Dihydrocodeine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 124. Europe Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 125. Europe Dihydrocodeine Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Dihydrocodeine Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Dihydrocodeine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Dihydrocodeine Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Dihydrocodeine Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Dihydrocodeine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 134. South America Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 135. South America Dihydrocodeine Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Dihydrocodeine Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Dihydrocodeine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Dihydrocodeine Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Dihydrocodeine Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Dihydrocodeine Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Dihydrocodeine Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Dihydrocodeine Sales by Type (2021-2026) & (K Units) Table 143. Global Dihydrocodeine Sales by Type (2027-2032) & (K Units) Table 144. Global Dihydrocodeine Sales Market Share by Type (2021-2026) Table 145. Global Dihydrocodeine Sales Market Share by Type (2027-2032) Table 146. Global Dihydrocodeine Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Dihydrocodeine Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Dihydrocodeine Revenue Market Share by Type (2021-2026) Table 149. Global Dihydrocodeine Revenue Market Share by Type (2027-2032) Table 150. Global Dihydrocodeine Price by Type (2021-2026) & (US$/Unit) Table 151. Global Dihydrocodeine Price by Type (2027-2032) & (US$/Unit) Table 152. Global Dihydrocodeine Sales by Application (2021-2026) & (K Units) Table 153. Global Dihydrocodeine Sales by Application (2027-2032) & (K Units) Table 154. Global Dihydrocodeine Sales Market Share by Application (2021-2026) Table 155. Global Dihydrocodeine Sales Market Share by Application (2027-2032) Table 156. Global Dihydrocodeine Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Dihydrocodeine Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Dihydrocodeine Revenue Market Share by Application (2021-2026) Table 159. Global Dihydrocodeine Revenue Market Share by Application (2027-2032) Table 160. Global Dihydrocodeine Price by Application (2021-2026) & (US$/Unit) Table 161. Global Dihydrocodeine Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Dihydrocodeine Distributors List Table 165. Dihydrocodeine Customers List Table 166. Dihydrocodeine Industry Trends Table 167. Dihydrocodeine Industry Drivers Table 168. Dihydrocodeine Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dihydrocodeine Product Image Figure 5. Global Dihydrocodeine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dihydrocodeine Market Size (2021-2032) & (US$ Million) Figure 7. Global Dihydrocodeine Sales (2021-2032) & (K Units) Figure 8. Global Dihydrocodeine Average Price (US$/Unit) & (2021-2032) Figure 9. Oral Product Image Figure 10. Injection Product Image Figure 11. Cough Suppressant Product Image Figure 12. Analgesic Product Image Figure 13. Global Dihydrocodeine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Dihydrocodeine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Dihydrocodeine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Dihydrocodeine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Dihydrocodeine Sales by Region in 2025 Figure 19. Global Dihydrocodeine Revenue by Region in 2025 Figure 20. North America Dihydrocodeine Market Size by Country in 2025 Figure 21. North America Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 22. North America Dihydrocodeine Revenue Market Share by Country (2021-2032) Figure 23. United States Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Dihydrocodeine Market Size by Country in 2025 Figure 26. Europe Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 27. Europe Dihydrocodeine Revenue Market Share by Country (2021-2032) Figure 28. Germany Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Dihydrocodeine Market Size by Country in 2025 Figure 34. Asia Pacific Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Dihydrocodeine Revenue Market Share by Country (2021-2032) Figure 36. China Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Dihydrocodeine Market Size by Country in 2025 Figure 45. South America Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 46. South America Dihydrocodeine Revenue Market Share by Country (2021-2032) Figure 47. Mexico Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Dihydrocodeine Market Size by Country in 2025 Figure 51. Middle East and Africa Dihydrocodeine Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Dihydrocodeine Revenue Market Share by Country (2021-2032) Figure 53. Turkey Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Dihydrocodeine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Dihydrocodeine Sales Market Share by Type (2021-2032) Figure 57. Global Dihydrocodeine Revenue Market Share by Type (2021-2032) Figure 58. Global Dihydrocodeine Price (US$/Unit) by Type (2021-2032) Figure 59. Global Dihydrocodeine Sales Market Share by Application (2021-2032) Figure 60. Global Dihydrocodeine Revenue Market Share by Application (2021-2032) Figure 61. Global Dihydrocodeine Price (US$/Unit) by Application (2021-2032) Figure 62. Dihydrocodeine Value Chain Figure 63. Dihydrocodeine Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Dihydrocodeine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Cough Suppressant
  • Analgesic
Companies covered
  • AHPL
  • Aspen Pharmacare
  • Auden Mckenzie Pharma
  • Daiichi Sankyo
  • Duopharma Biotech Berhad
  • Fuso Pharmaceutical
  • G.L. Pharma
  • Martindale-Hubbell
  • Mundipharma
  • Napp Pharmaceuticals
  • Nichi-Iko Pharmaceutical
  • Takata Pharmaceutical
  • Teofarma
  • Toyo Seikan Group
  • Wockhardt
  • WraSer
  • GlaxoSmithKline
  • Teva

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dihydrocodeine Market Size (2021-2032)
  4. 2.2.2 Global Dihydrocodeine Sales (2021-2032)
  5. 2.2.3 Global Dihydrocodeine Market Average Price (2021-2032)
  6. 2.3 Dihydrocodeine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Oral
  9. 2.3.3 Injection
  10. 2.4 Dihydrocodeine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Cough Suppressant
  13. 2.4.3 Analgesic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dihydrocodeine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dihydrocodeine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Dihydrocodeine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dihydrocodeine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dihydrocodeine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dihydrocodeine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dihydrocodeine, Product Type & Application
  8. 3.8 Global Manufacturers of Dihydrocodeine, Established Date
  9. 3.9 Global Dihydrocodeine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AHPL
  2. 4.1.1 AHPL Company Information
  3. 4.1.2 AHPL Business Overview
  4. 4.1.3 AHPL Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AHPL Dihydrocodeine Product Portfolio
  6. 4.1.5 AHPL Recent Developments
  7. 4.2 Aspen Pharmacare
  8. 4.2.1 Aspen Pharmacare Company Information
  9. 4.2.2 Aspen Pharmacare Business Overview
  10. 4.2.3 Aspen Pharmacare Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aspen Pharmacare Dihydrocodeine Product Portfolio
  12. 4.2.5 Aspen Pharmacare Recent Developments
  13. 4.3 Auden Mckenzie Pharma
  14. 4.3.1 Auden Mckenzie Pharma Company Information
  15. 4.3.2 Auden Mckenzie Pharma Business Overview
  16. 4.3.3 Auden Mckenzie Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Auden Mckenzie Pharma Dihydrocodeine Product Portfolio
  18. 4.3.5 Auden Mckenzie Pharma Recent Developments
  19. 4.4 Daiichi Sankyo
  20. 4.4.1 Daiichi Sankyo Company Information
  21. 4.4.2 Daiichi Sankyo Business Overview
  22. 4.4.3 Daiichi Sankyo Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Daiichi Sankyo Dihydrocodeine Product Portfolio
  24. 4.4.5 Daiichi Sankyo Recent Developments
  25. 4.5 Duopharma Biotech Berhad
  26. 4.5.1 Duopharma Biotech Berhad Company Information
  27. 4.5.2 Duopharma Biotech Berhad Business Overview
  28. 4.5.3 Duopharma Biotech Berhad Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Duopharma Biotech Berhad Dihydrocodeine Product Portfolio
  30. 4.5.5 Duopharma Biotech Berhad Recent Developments
  31. 4.6 Fuso Pharmaceutical
  32. 4.6.1 Fuso Pharmaceutical Company Information
  33. 4.6.2 Fuso Pharmaceutical Business Overview
  34. 4.6.3 Fuso Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fuso Pharmaceutical Dihydrocodeine Product Portfolio
  36. 4.6.5 Fuso Pharmaceutical Recent Developments
  37. 4.7 G.L. Pharma
  38. 4.7.1 G.L. Pharma Company Information
  39. 4.7.2 G.L. Pharma Business Overview
  40. 4.7.3 G.L. Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 G.L. Pharma Dihydrocodeine Product Portfolio
  42. 4.7.5 G.L. Pharma Recent Developments
  43. 4.8 Martindale-Hubbell
  44. 4.8.1 Martindale-Hubbell Company Information
  45. 4.8.2 Martindale-Hubbell Business Overview
  46. 4.8.3 Martindale-Hubbell Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Martindale-Hubbell Dihydrocodeine Product Portfolio
  48. 4.8.5 Martindale-Hubbell Recent Developments
  49. 4.9 Mundipharma
  50. 4.9.1 Mundipharma Company Information
  51. 4.9.2 Mundipharma Business Overview
  52. 4.9.3 Mundipharma Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mundipharma Dihydrocodeine Product Portfolio
  54. 4.9.5 Mundipharma Recent Developments
  55. 4.10 Napp Pharmaceuticals
  56. 4.10.1 Napp Pharmaceuticals Company Information
  57. 4.10.2 Napp Pharmaceuticals Business Overview
  58. 4.10.3 Napp Pharmaceuticals Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Napp Pharmaceuticals Dihydrocodeine Product Portfolio
  60. 4.10.5 Napp Pharmaceuticals Recent Developments
  61. 4.11 Nichi-Iko Pharmaceutical
  62. 4.11.1 Nichi-Iko Pharmaceutical Company Information
  63. 4.11.2 Nichi-Iko Pharmaceutical Business Overview
  64. 4.11.3 Nichi-Iko Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nichi-Iko Pharmaceutical Dihydrocodeine Product Portfolio
  66. 4.11.5 Nichi-Iko Pharmaceutical Recent Developments
  67. 4.12 Takata Pharmaceutical
  68. 4.12.1 Takata Pharmaceutical Company Information
  69. 4.12.2 Takata Pharmaceutical Business Overview
  70. 4.12.3 Takata Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Takata Pharmaceutical Dihydrocodeine Product Portfolio
  72. 4.12.5 Takata Pharmaceutical Recent Developments
  73. 4.13 Teofarma
  74. 4.13.1 Teofarma Company Information
  75. 4.13.2 Teofarma Business Overview
  76. 4.13.3 Teofarma Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Teofarma Dihydrocodeine Product Portfolio
  78. 4.13.5 Teofarma Recent Developments
  79. 4.14 Toyo Seikan Group
  80. 4.14.1 Toyo Seikan Group Company Information
  81. 4.14.2 Toyo Seikan Group Business Overview
  82. 4.14.3 Toyo Seikan Group Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Toyo Seikan Group Dihydrocodeine Product Portfolio
  84. 4.14.5 Toyo Seikan Group Recent Developments
  85. 4.15 Wockhardt
  86. 4.15.1 Wockhardt Company Information
  87. 4.15.2 Wockhardt Business Overview
  88. 4.15.3 Wockhardt Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Wockhardt Dihydrocodeine Product Portfolio
  90. 4.15.5 Wockhardt Recent Developments
  91. 4.16 WraSer
  92. 4.16.1 WraSer Company Information
  93. 4.16.2 WraSer Business Overview
  94. 4.16.3 WraSer Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 WraSer Dihydrocodeine Product Portfolio
  96. 4.16.5 WraSer Recent Developments
  97. 4.17 GlaxoSmithKline
  98. 4.17.1 GlaxoSmithKline Company Information
  99. 4.17.2 GlaxoSmithKline Business Overview
  100. 4.17.3 GlaxoSmithKline Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 GlaxoSmithKline Dihydrocodeine Product Portfolio
  102. 4.17.5 GlaxoSmithKline Recent Developments
  103. 4.18 Teva
  104. 4.18.1 Teva Company Information
  105. 4.18.2 Teva Business Overview
  106. 4.18.3 Teva Dihydrocodeine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Teva Dihydrocodeine Product Portfolio
  108. 4.18.5 Teva Recent Developments
5 Global Dihydrocodeine Market Scenario by Region
  1. 5.1 Global Dihydrocodeine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dihydrocodeine Sales by Region: 2021-2032
  3. 5.2.1 Global Dihydrocodeine Sales by Region: 2021-2026
  4. 5.2.2 Global Dihydrocodeine Sales by Region: 2027-2032
  5. 5.3 Global Dihydrocodeine Revenue by Region: 2021-2032
  6. 5.3.1 Global Dihydrocodeine Revenue by Region: 2021-2026
  7. 5.3.2 Global Dihydrocodeine Revenue by Region: 2027-2032
  8. 5.4 North America Dihydrocodeine Market Facts & Figures by Country
  9. 5.4.1 North America Dihydrocodeine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dihydrocodeine Sales by Country (2021-2032)
  11. 5.4.3 North America Dihydrocodeine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Dihydrocodeine Market Facts & Figures by Country
  15. 5.5.1 Europe Dihydrocodeine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Dihydrocodeine Sales by Country (2021-2032)
  17. 5.5.3 Europe Dihydrocodeine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Dihydrocodeine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Dihydrocodeine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Dihydrocodeine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Dihydrocodeine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Dihydrocodeine Market Facts & Figures by Country
  35. 5.7.1 South America Dihydrocodeine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Dihydrocodeine Sales by Country (2021-2032)
  37. 5.7.3 South America Dihydrocodeine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Dihydrocodeine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Dihydrocodeine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Dihydrocodeine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Dihydrocodeine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Dihydrocodeine Sales by Type (2021-2032)
  2. 6.1.1 Global Dihydrocodeine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Dihydrocodeine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dihydrocodeine Revenue by Type (2021-2032)
  5. 6.2.1 Global Dihydrocodeine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dihydrocodeine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dihydrocodeine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dihydrocodeine Sales by Application (2021-2032)
  2. 7.1.1 Global Dihydrocodeine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Dihydrocodeine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dihydrocodeine Revenue by Application (2021-2032)
  5. 7.2.1 Global Dihydrocodeine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dihydrocodeine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dihydrocodeine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dihydrocodeine Value Chain Analysis
  2. 8.1.1 Dihydrocodeine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dihydrocodeine Production Mode & Process
  5. 8.2 Dihydrocodeine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dihydrocodeine Distributors
  8. 8.2.3 Dihydrocodeine Customers
9 Global Dihydrocodeine Analyzing Market Dynamics
  1. 9.1 Dihydrocodeine Industry Trends
  2. 9.2 Dihydrocodeine Industry Drivers
  3. 9.3 Dihydrocodeine Industry Opportunities and Challenges
  4. 9.4 Dihydrocodeine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst